UPDATE : Monday, March 30, 2020
상단여백
[Column] Are we ready for COVID-19’s arrival at schools? by Korea Biomedical Review 2020-03-20 18:21
[Column] Temporary nod for telemedicine against COVID-19 too hasty  by Choi Yoon Sup 2020-03-17 11:01
[Column] Will ‘third wave’ of COVID-19 hit Korea? by Yoo Jin-hong 2020-03-16 17:08
[Column ] Anthelmintics as potential anticancer drugs? by Heo Dae-seog 2020-02-17 18:26
[Column] Meaning of competent AI doctor by Choi Yoon Sup 2020-02-17 17:00
라인
[Column] In dealing with new coronavirus, luck could run out by Kang Yang-gu 2020-02-07 16:48
[Column] New coronavirus spread behooves upgraded quarantine of nation by Hong Sung-Tae 2020-02-06 18:20
[Column] Arduous march has begun to combat new coronavirus by Yoo Jin-hong 2020-02-03 18:23
[Column] Navigating a changing healthcare landscape with focus on patient centricity by Peter Soelkner 2019-12-19 12:10
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners by Lee Han-soo 2019-12-11 17:37
라인
[Column] Korea should do better in diabetes management by Park Tae-sun 2019-11-08 15:57
[Column] Digital healthcare for efficient distribution of medical resources by Song Seung-jae 2019-09-10 15:46
[Reporter’s Notebook] SillaJen should be ashamed of itself by Jeong Sae-im 2019-08-07 13:59
[Column] Drug regulator needs adequate expertise to promote medical devices by Korea Biomedical Review 2019-07-31 16:59
[Reporter's Notebook] Korean drugmakers should increase presence at global conventions by Lee Han-soo 2019-06-21 15:57
라인
[Reporter’s Notebook] ‘Wanna know what’s going on with MSD Korea?’ by Jeong Sae-im 2019-05-21 11:44
[Reporter’s Notebook] Roche agreed, MSD and BMS should, too by Kim Yun-mi 2019-05-07 14:30
[Reporter’s Notebook]MFDS incapable of reviewing new drugs? by Lee Hye-seon 2019-04-29 16:12
[Column] Measles and fake news by Park Ji-wook 2019-04-16 14:02
[Reporter’s Notebook] Concerns over TB risk rise amid more use of TNF-α inhibitors by Kim Yun-mi 2019-03-29 17:21
여백
여백
여백
여백
Back to Top